Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Clemmie70on Oct 05, 2011 7:29am
185 Views
Post# 19120060

RE: RE: RE: Green in a Sea of Red

RE: RE: RE: Green in a Sea of Redwell proof is in the pudding. I see what Oximunal has done for my 15 year old Lhasa and it is fantastic. She has spark that she she hasn't had in years, and the little glint in her eye of the devil she used to be. I am sold and have been doing my part to tell others. I wish I had something in the cupboard that gave me the kind of lift that Oximunal has given my dog. Kind of like a Viagra for the soul! lol!

I agree that the big hit here will be the food additive as this will address concerns worldwide as discussed in earlier posts. But it is nice to see they have the pet products as well that  will continue to grow and have an increased revenue stream. While it is all based on the OxC-beta, it is nice to see CFR is not a one trick pony.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities